Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1CNS 1Breast 1

Conditions

Breast Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Hot Flashes 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Docetaxel 8Radiotherapy 2vandetanib 1tanespimycin 1oblimersen 1entinostat 1X-Ray Therapy 1Vorinostat 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Phlebotomy 1Pemetrexed 1Nicotine 1Moxibustion 1Irinotecan 1Indinavir 1Hypericum extract LI 160 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Fentanyl 1FPP(RGD)2 1Erlotinib Hydrochloride 1Cyclophosphamide 1Cryosurgery 1Cisplatin 1Capecitabine 1Acupuncture Therapy 17-hydroxystaurosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Hypericum extract LI 160 × Breast × Clear all
NCT00041171 2016-07-12

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Alliance for Clinical Trials in Oncology

Phase 3 Withdrawn
BreastCNSGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡